United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - adapalene 1 mg in 1 g - adapalene gel is indicated for the topical treatment of acne vulgaris. adapalene gel should not be administered to individuals who are hypersensitive to adapalene or any of the components in the vehicle gel.

United States - English - NLM (National Library of Medicine)

call inc (d.b.a rochester pharmaceuticals) - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - adapalene 1 mg in 1 ml - adapalene topical solution 0.1% is indicated for the topical treatment of acne vulgaris. adapalene topical solution 0.1% should not be administered to individuals who are hypersensitive to adapalene or any of the components in the vehicle solution.

United States - English - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - adapalene 1 mg in 1 g - adapalene gel, 0.1% is indicated for the topical treatment of acne vulgaris. adapalene gel should not be administered to individuals who are hypersensitive to adapalene or any of the components in the vehicle gel.

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - indapamide hemihydrate -

United States - English - NLM (National Library of Medicine)

dr. reddy's laboratories limited - fondaparinux sodium (unii: x0q6n9usoz) (fondaparinux - unii:j177fow5jl) - fondaparinux sodium 2.5 mg in 0.5 ml - fondaparinux sodium injection is indicated for the prophylaxis of deep vein thrombosis (dvt), which may lead to pulmonary embolism (pe): - in patients undergoing hip fracture surgery, including extended prophylaxis; - in patients undergoing hip replacement surgery; - in patients undergoing knee replacement surgery; - in patients undergoing abdominal surgery who are at risk for thromboembolic complications. fondaparinux sodium injection is indicated for the treatment of acute deep vein thrombosis when administered in conjunction with warfarin sodium. fondaparinux sodium injection is indicated for the treatment of acute pulmonary embolism when administered in conjunction with warfarin sodium when initial therapy is administered in the hospital. fondaparinux sodium injection is contraindicated in the following conditions: - severe renal impairment (creatinine clearance [crcl] <30 ml/min). [see warnings and precautions (5.3) and use in specific populations (8.6)] - active major bleeding. - bacterial endocarditi

United States - English - NLM (National Library of Medicine)

dr. reddy's laboratories inc. - fondaparinux sodium (unii: x0q6n9usoz) (fondaparinux - unii:j177fow5jl) - fondaparinux sodium 2.5 mg in 0.5 ml - fondaparinux sodium injection is indicated for the prophylaxis of deep vein thrombosis (dvt), which may lead to pulmonary embolism (pe): - in patients undergoing hip fracture surgery, including extended prophylaxis; - in patients undergoing hip replacement surgery; - in patients undergoing knee replacement surgery; - in patients undergoing abdominal surgery who are at risk for thromboembolic complications. fondaparinux sodium injection is indicated for the treatment of acute deep vein thrombosis when administered in conjunction with warfarin sodium. fondaparinux sodium injection is indicated for the treatment of acute pulmonary embolism when administered in conjunction with warfarin sodium when initial therapy is administered in the hospital. fondaparinux sodium injection is contraindicated in the following conditions: - severe renal impairment (creatinine clearance [crcl] <30 ml/min). [see warnings and precautions (5.3) and use in specific populations (8.6)] - active major bleeding. - bacterial endocarditis

United States - English - NLM (National Library of Medicine)

avkare - indapamide (unii: f089i0511l) (indapamide - unii:f089i0511l) - indapamide 1.25 mg - indapamide tablets are indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs. indapamide tablets are also indicated for the treatment of salt and fluid retention associated with congestive heart failure. usage in pregnancy: the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard (see precautions). diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. indapamide is indicated in pregnancy when edema is due to pathologic causes, just as it is in the absence of pregnancy (however, see precautions). dependent edema in pregnancy, resulting from restriction of venous return by the expanded uterus, is properly treated through elevation of the lower extremities

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - indapamide (unii: f089i0511l) (indapamide - unii:f089i0511l) - indapamide 1.25 mg - indapamide tablets are indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs. indapamide tablets are also indicated for the treatment of salt and fluid retention associated with congestive heart failure. usage in pregnancy: the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard (see precautions ). diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. indapamide is indicated in pregnancy when edema is due to pathologic causes, just as it is in the absence of pregnancy (however, see precautions ). dependent edema in pregnancy, resulting from restriction of venous return by the expanded uterus, is properly treated through elevation of the lower extremities and use of

United States - English - NLM (National Library of Medicine)

ani pharmaceuticals, inc. - indapamide (unii: f089i0511l) (indapamide - unii:f089i0511l) - indapamide 1.25 mg - indapamide tablets are indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs. indapamide tablets are also indicated for the treatment of salt and fluid retention associated with congestive heart failure. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard (see precautions ). diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. indapamide is indicated in pregnancy when edema is due to pathologic causes, just as it is in the absence of pregnancy (however, see precautions ). dependent edema in pregnancy, resulting from restriction of venous return by the expanded uterus, is properly treated through elevation of the lower extremities and use of support hose; use

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

strides pharma uk ltd - indapamide hemihydrate - oral tablet - 2.5mg